• 1. Enabling high-throughput single-animal gene-expression studies with molecular and micro-scale technologies
  Jason Wan Lab Chip, 2020,20, 4528-4538
• 2. Enantiocontrolled construction of sistodiolynne, an unusual polyketide from the wood-decay fungus Sistrema raduloides
  Chem. Commun., 1997, 767-768
• 3. Evidence that the availability of an allylic hydrogen governs the regioselectivity of the Wacker oxidation
  Matthew J. Gaunt,Jinquan Yu,Jonathan B. Spencer Chem. Commun., 2001, 1844-1845
• 4. Fate of Sb(v) and Sb(iii) species along a gradient of pH and oxygen concentration in the Carnoulès mine waters (Southern France)
  Eléonore Resongles,Corinne Casiot,Fran?oise Elbaz-Poulichet,Rémi Freydier,Odile Bruneel,Christine Piot,Sophie Delpoux,Aurélie Volant,Angélique Desoeuvre Environ. Sci.: Processes Impacts, 2013,15, 1536-1544
• 5. Emerging investigator series: bacteriophages as nano engineering tools for quality monitoring and pathogen detection in water and wastewater
  Fereshteh Bayat Environ. Sci.: Nano, 2021,8, 367-389

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Benzofurans Benzofurans
• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Benzofurans

Recent Advances in the Study of 5-methyl-1-benzofuran-2-carbonitrile (CAS: 35351-43-0) in Chemical Biology and Pharmaceutical Research

The compound 5-methyl-1-benzofuran-2-carbonitrile (CAS: 35351-43-0) has recently garnered significant attention in the field of chemical biology and pharmaceutical research due to its versatile applications in drug discovery and development. This heterocyclic compound, characterized by a benzofuran core substituted with a methyl group at the 5-position and a nitrile group at the 2-position, exhibits a unique combination of chemical reactivity and biological activity. Recent studies have explored its potential as a building block for the synthesis of novel bioactive molecules and as a lead compound for therapeutic applications.

One of the key areas of interest is the role of 5-methyl-1-benzofuran-2-carbonitrile in the development of kinase inhibitors. Kinases are critical targets in the treatment of various diseases, including cancer and inflammatory disorders. Researchers have demonstrated that derivatives of this compound can effectively modulate kinase activity, offering promising avenues for the design of selective inhibitors. For instance, a 2023 study published in the Journal of Medicinal Chemistry reported the synthesis and evaluation of a series of 5-methyl-1-benzofuran-2-carbonitrile derivatives, highlighting their potent inhibitory effects on specific kinases implicated in tumor growth.

In addition to its applications in kinase inhibition, 5-methyl-1-benzofuran-2-carbonitrile has been investigated for its antimicrobial properties. A recent study in Bioorganic & Medicinal Chemistry Letters described the synthesis of novel analogs and their evaluation against a panel of bacterial and fungal pathogens. The results indicated that certain derivatives exhibited broad-spectrum antimicrobial activity, with minimal cytotoxicity to mammalian cells, suggesting their potential as candidates for the development of new antibiotics.

The compound's structural features also make it a valuable intermediate in organic synthesis. Researchers have utilized 5-methyl-1-benzofuran-2-carbonitrile as a precursor for the construction of more complex heterocyclic systems, which are often found in pharmaceuticals. A 2022 study in Organic Letters detailed a novel synthetic route that leverages the reactivity of the nitrile group to generate diverse benzofuran-based scaffolds, further expanding the compound's utility in medicinal chemistry.

Despite these promising findings, challenges remain in optimizing the pharmacokinetic and pharmacodynamic properties of 5-methyl-1-benzofuran-2-carbonitrile derivatives. Recent efforts have focused on improving solubility, bioavailability, and target specificity through structural modifications. Computational modeling and high-throughput screening have played pivotal roles in identifying optimal derivatives, as reported in a 2023 ACS Chemical Biology article.

In conclusion, 5-methyl-1-benzofuran-2-carbonitrile (CAS: 35351-43-0) represents a versatile and promising scaffold in chemical biology and pharmaceutical research. Its applications in kinase inhibition, antimicrobial therapy, and organic synthesis underscore its potential as a valuable tool for drug discovery. Ongoing research aims to address existing challenges and further elucidate its mechanistic insights, paving the way for the development of novel therapeutics.

• 53020-44-3(2-Benzofurancarbonitrile, 6-hydroxy-)
• 53020-40-9(4-hydroxybenzofuran-2-carbonitrile)
• 41717-32-2(1-Benzofuran-2-carbonitrile)
• 515163-42-5(2-methyl-7-Benzofurancarbonitrile)
• 53020-42-1(5-Hydroxybenzofuran-2-carbonitrile)
• 916737-84-3(2-Benzofurancarbonitrile, 5-amino-)
• 74-20-4(2,6-dimethylbenzofuran)
• 16238-12-3(2-methyl-5-Benzofurancarbonitrile)
• 515163-40-3(2-methyl-4-Benzofurancarbonitrile)
• 200185-84-8(2-methyl-6-Benzofurancarbonitrile)